Skip to main content

Table 1 Clinical characteristics of EOC patients with high and low GAS5 risk scores

From: Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis

  Case(n) GAS5 P
Low-risk (n) High-risk (n)
Age
  ≥ mean 33 17 16 0.269
  < mean 20 8 12  
FIGO Stage
 I- II 22 16 6 0.007*
 III-IV 31 10 21  
Histological Type
 I 11 7 4 0.024*
 II- III 42 16 26  
Residual tumor (cm)
  < 1 cm 34 18 16 0.332
  ≥ 1 cm 19 8 11  
Histology
 Mucinous 7 3 4 0.402
 Serous 41 17 24  
 Endometrioid 3 1 2  
 Clear cell 2 1 1  
Lymphatic metastasis
 No 20 8 12 0.257
 Yes 33 14 19  
Ascites
 No 21 14 7 0.096
 Yes 32 13 19  
  1. P Values are calculated by X2 test or Fisher’s exact test